A Study of Atezolizumab in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower131]
Clinical trial NCT02367794 · COMPLETED
Trial details
- NCT number
- NCT02367794
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-11
- Primary completion
- 2018-10-03
- Enrollment
- 1021
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.